drugset / Trial / NCT03604289
Angiotensin 1-7 in Obesity Hypertension
RandomizedCrossoverQuadruple-blindBasic science
Summary
The purpose of this study is to find out if the investigational drug angiotensin-(1-7) improves cardiovascular health in patients with obesity and high blood pressure.
Timeline
- Start
- 2019-04-01
- Primary completion
- 2023-05-03
- Completion
- 2023-06-03
Outcome
Outcome not reported
Stopped (Business): “Funding terminated”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | talfirastide | Peptide | 8 unknown | Intravenous |